Retinitis pigmentosa trials in China

In China 11 Also abroad 68

11 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Early phase 1Taking people
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Where
Beijing
Age
18 years and over
People
9
Run by
Peking University Third Hospital
See details and how to joinNCT05805007
Early phase 1Taking people
Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
Where
Beijing
Age
18 years to 55 years
People
6
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07656753
Phase 1/2Taking people
Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Where
Beijing
Age
18 years and over
People
18
Run by
Chigenovo Co., Ltd
See details and how to joinNCT06952842
No phaseTaking people
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
Where
Guangzhou, Shenzhen, Wuhan
Age
18 years and over
People
88
Run by
Zhongshan Ophthalmic Center, Sun Yat-sen University
See details and how to joinNCT07126470
Early phase 1Taking people
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
Where
Beijing
Age
18 years to 65 years
People
12
Run by
Augelux Therapeutics
See details and how to joinNCT06292650
Early phase 1Taking people
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
Where
Shanghai
Age
4 years and over
People
13
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07063030
Early phase 1Not yet taking people in China
UGX202 Injection in Patients With Advanced Retinitis Pigmentosa
Where
Shanghai
Age
18 years and over
People
6
Run by
Suzhou UgeneX Therapeutics Co., Ltd.
See details and how to joinNCT07311863
No phaseTaking people
Pilot Study of AuTNA I
Where
Shanghai
Age
18 years to 70 years
People
7
Run by
Eye & ENT Hospital of Fudan University
See details and how to joinNCT05853107
Phase 3Not yet taking people in China
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
Where
Guangzhou
Age
18 years to 60 years
People
126
Run by
Zhongshan Ophthalmic Center, Sun Yat-sen University
See details and how to joinNCT07082855
Phase 1Taking people
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Where
Shanghai
Age
18 years and over
People
21
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06936787
Early phase 1Taking people
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
Where
Beijing, Shanghai
Age
8 years to 45 years
People
18
Run by
Frontera Therapeutics
See details and how to joinNCT05874310